Local view for "http://purl.org/linkedpolitics/eu/plenary/2004-01-13-Speech-2-163"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20040113.6.2-163"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, on 30 August last year, an important decision was made. On the eve of CancĂșn, the United States, the EU and the developing countries agreed to flesh out paragraph 6 of the Doha Declaration, which has to do with the production of medicines for developing countries undergoing serious health crises. The agreement is not brilliant, but it is a start, although we now have to think about implementing it. I have meanwhile gleaned from the press that the United States is backtracking from it. That is why now is the time for the European Union to take a few convincing steps. So far, though, the European Union is showing little initiative. An opportunity to carry out in practice the decision of 30 August was recently lost with the review of legislation on pharmaceuticals. The Commission appears to be of the opinion that this matter belongs in Community and national patent legislation, but that is insufficient. The Community patent is still some way off and does not involve existing patents. Moreover, the Community patent does not affect data protection in any way.
The health crisis in Africa is an urgent problem. Last month, it became known that AIDS has claimed five million casualties over the past year. It is beyond me why the EU has not so far been prepared to do what the EU agreed upon prior to the Conference of CancĂșn.
Commissioner, what I want to know from you is when the European Union will have taken the legal measures in order to speed up the production of generic medicines for developing countries. What pledges can you make to Parliament today?"@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples